These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17934489)

  • 1. Transcriptional dysregulation during myeloid transformation in AML.
    Pabst T; Mueller BU
    Oncogene; 2007 Oct; 26(47):6829-37. PubMed ID: 17934489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexity of CEBPA dysregulation in human acute myeloid leukemia.
    Pabst T; Mueller BU
    Clin Cancer Res; 2009 Sep; 15(17):5303-7. PubMed ID: 19706798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the unfolded protein response in human acute myeloid leukemia.
    Schardt JA; Mueller BU; Pabst T
    Methods Enzymol; 2011; 489():227-43. PubMed ID: 21266233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of human leukemias: new insights into therapy.
    Gilliland DG
    Semin Hematol; 2002 Oct; 39(4 Suppl 3):6-11. PubMed ID: 12447846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia.
    Mullican SE; Zhang S; Konopleva M; Ruvolo V; Andreeff M; Milbrandt J; Conneely OM
    Nat Med; 2007 Jun; 13(6):730-5. PubMed ID: 17515897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
    Pabst T; Eyholzer M; Haefliger S; Schardt J; Mueller BU
    J Clin Oncol; 2008 Nov; 26(31):5088-93. PubMed ID: 18768433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.
    Yanagida M; Osato M; Yamashita N; Liqun H; Jacob B; Wu F; Cao X; Nakamura T; Yokomizo T; Takahashi S; Yamamoto M; Shigesada K; Ito Y
    Oncogene; 2005 Jun; 24(28):4477-85. PubMed ID: 15856017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
    Wang GG; Cai L; Pasillas MP; Kamps MP
    Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage.
    Porse BT; Bryder D; Theilgaard-Mönch K; Hasemann MS; Anderson K; Damgaard I; Jacobsen SE; Nerlov C
    J Exp Med; 2005 Jul; 202(1):85-96. PubMed ID: 15983063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6 protein in acute myeloid leukemia.
    Barjesteh van Waalwijk van Doorn-Khosrovani S; Spensberger D; de Knegt Y; Tang M; Löwenberg B; Delwel R
    Oncogene; 2005 Jun; 24(25):4129-37. PubMed ID: 15806161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
    Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
    Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AML1/ETO-induced survivin expression inhibits transcriptional regulation of myeloid differentiation.
    Balkhi MY; Christopeit M; Chen Y; Geletu M; Behre G
    Exp Hematol; 2008 Nov; 36(11):1449-60. PubMed ID: 18687517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gatekeeper function of the RUNX1 transcription factor in acute leukemia.
    Niebuhr B; Fischer M; Täger M; Cammenga J; Stocking C
    Blood Cells Mol Dis; 2008; 40(2):211-8. PubMed ID: 17920312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting epigenetic changes in acute myeloid leukemia.
    Blum W; Marcucci G
    Clin Adv Hematol Oncol; 2005 Nov; 3(11):855-65, 882. PubMed ID: 16491631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
    Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothesis: myeloid-restricted hematopoietic stem cells with self-renewal capacity may be the transformation site in acute myeloid leukemia.
    Satoh C; Ogata K
    Leuk Res; 2006 Apr; 30(4):491-5. PubMed ID: 16183117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PU.1 and CEBPA expression in acute myeloid leukemia.
    D'Alò F; Di Ruscio A; Guidi F; Fabiani E; Greco M; Rumi C; Hohaus S; Voso MT; Leone G
    Leuk Res; 2008 Sep; 32(9):1448-53. PubMed ID: 18308386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of AML1 in non-M0 acute myeloid leukemia: six novel mutations and a high incidence of cooperative events in a South-east Asian population.
    Auewarakul CU; Leecharendkeat A; Thongnoppakhun W; Limwongse C; Tocharoentanaphol C
    Haematologica; 2006 May; 91(5):675-8. PubMed ID: 16627249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations.
    Fröhling S; Schlenk RF; Krauter J; Thiede C; Ehninger G; Haase D; Harder L; Kreitmeier S; Scholl C; Caligiuri MA; Bloomfield CD; Döhner H; Döhner K
    Genes Chromosomes Cancer; 2005 Apr; 42(4):427-32. PubMed ID: 15645492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.